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ABSTRACT: This study was designed to assess the changes in plasma lipids and lipoproteins, in particular high-
density lipoprotein (HDLC) in patients suffering from different types of cardiovascular disease (CVD) in South-
western Nigeria. Patients were drawn from different socioeconomic classes in order to determine the effect of this 
factor on CVD in Nigeria. One hundred and seventy (74 males, 96 females) CVD patients (hypertensive heart disease 
(n=48), hypertension (n=59), ischaemic heart disease (n=49), myocardial infarction (n=4)) with a mean age of 
45.3±13.2 years were selected. Fifty-eight individuals (31 males and 27 female) with mean age of 44.8±11.7 years 
were included as controls. Result showed significant increases in mean plasma total cholesterol (TC) (P < 0.05), 
triglyceride and low density lipoproteins (LDLC) (P < 0.01), LDLC: HDLC (p < 0.001), as well as in systolic and 
diastolic blood pressures (p < 0.001), while plasma HDLC (p < 0.01) and HDLC:TC (p < 0.001) showed significant 
decreases when compared with the corresponding mean control values. There were graded decreases in plasma 
HDLC in the different socioeconomic classes. The lowest mean plasma HDLC was found in IHD patients. This study 
has uncovered variations in plasma lipids and lipoproteins among patients of CVD within the different 
socioeconomic classes in South-western Nigeria. 
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INTRODUCTION 
Premature cardiovascular disease is emerging as a major 
cause of death in developing countries (Beaglehole, 1992). 
Among the principal markers of increased risk of CVD are 
raised plasma total cholesterol and low density lipoproteins 
as well as decreased high density lipoprotein. Whether these 
are related to social class differences and subtypes of CVD in 
general is uncertain, but few studies have shown an 
association between socioeconomic classes and plasma lipid 
and lipoprotein changes (Hesis et al., 1980, Wamala et al., 
1997; Darmon and Drewnowski, 2008). These earlier studies 
have however neither considered the socioeconomic status 
and their relevance in different subtypes of CVD. Some 
studies have indicated that socioeconomic status (SES) is 
inversely associated with increased CVD risk factors and 
diseases, (Leupker et al., 1993; Wamala et al., 1997) 
whereas others have reported a positive association 
(Woodward et al., 1992). 
In Nigeria CVD has become one of the major causes of death 
especially in urban areas (Akinkugbe, 1976). An earlier study 
by Taylor and Agbedana (1983) indicated that circulating low 
level of plasma high density lipoprotein cholesterol (HDLC) 
was positively associated with SES in free living individuals. 
Similarly, in Swedish free-living women aged 30-65 years, 
(Wamala et al., 1997) reported that plasma HDLC levels 
were associated with low SES. Detailed studies on possible 
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relationship between SES and circulating lipoproteins in 
patients with subtypes of CVD are very scanty in the Nigerian 
African populations. It is thought that the changing patterns of 
CVD risk factors may be related to increasing adoption of 
Westernized lifestyle by different Nigerian African 
populations.  
The aim of this study was to determine plasma lipids and 
lipoproteins profiles, in particular low HDLC and increased 
LDLC: HDLC ratio in patients suffering from different forms of 
CVD in a Nigeria community. In addition, we assessed the 
effects of socioeconomic status on these biochemical 
parameters that are relevant to cardiovascular diseases. 
MATERIALS AND METHODS 
Subjects 
One hundred and seventy (74 males, 96 females) patients 
suffering from different types of CVD made up of 
hypertensive heart diseases (HHD) (n=48). Hypertension 
(HT) (n=59), ischaemic heart diseases (IHD) (n=49), 
myocardial infarction (MI) (n=14) as diagnosed by the 
attending Consultant Cardiologist were randomly selected at 
the Cardiac Unit of the Department of Medicine University 
College Hospital Ibadan, Nigeria. The patients were aged 
between 20-51 years with a mean age of 45.3± 13.2 years. 
The random selection was drawn out of a total of 480 
patients who were either attending clinic or on admission in 
the cardiac ward unit of the University College Hospital 
Ibadan. Data from the completed questionnaire indicating the 
educational level, occupation, income (earning) and living 
conditions such as ownership of material goods were used 
as a measure of socio-economic status to classify the 
subjects into low (petty traders, famers, artisans, cleaners 
and junior staff in public offices (with primary/secondary 
education), middle (workers in the senior level cadre with 
university or polytechnic/higher education) and high income 
(executive business class, captain of industries. and directors 
of institutions) groups as adopted by Ebesunun et al., (2008) 
in an earlier study in this community. A written/oral informed 
consent was obtained from each patient to participate in the 
study. Fifty-eight (31 males and 27 female) healthy 
volunteers (aged between 19-48 years with mean 44.8±11.7 
years) from the same community were selected as controls 
after medical examination by the attendant Consultant 
Cardiologist. The random selection was drawn out of a total 
of 120 individuals. Those with history of diabetes, liver 
disease, renal dysfunction and any other disease conditions 
that could affect the outcome of the results were excluded 
from the study. The control subjects were classified as low, 
middle and high-income groups using the same criteria as for 
the patients. Ethical approval was obtained from the Medical 
Ethics Committee of the University of Ibadan and the 
University College Hospital, Ibadan, Nigeria. The size of the 
sample was estimated based on the 10% prevalence rate of 
CVD in Nigeria (Akinkugbe, 1976) 
Methods 
Blood samples were drawn in the morning after an overnight 
fast (10–14 hours) into EDTA bottles (1 mg/ml blood) and 
immediately placed on ice bag until centrifuged. Plasma 
samples were collected after centrifugation and stored at –70 
0C until analysed. Total cholesterol was analysed based on 
the method of Allian et al., (1974), High-density lipoprotein 
was determined after the isolation of LDLC and VLDLC from 
serum by precipitation. The cholesterol content of the 
supernatant cholesterol was measured enzymatically based 
on the method of Allian et al., (1974). The plasma triglyceride 
was estimated using an enzymatic colorimetric procedure 
based on the method of Buccolo and David (1973). The low 
density lipoprotein cholesterol was calculated using the 




Figure 1: Distribution of all subjects within the socio-
economic classes. HTN= Hypertension; IHD= Ischaemic 
heart disease; MI=Myocardial infarction; HHD= 
Hypertensive heart disease. 
 
The accuracy and precision of all biochemical tests were 
monitored using commercial quality control samples within 
each batch of test assay. 
Blood pressure was measured on the left arm while the 
subjects were seated or ambulant (average of two readings 
were taken), weight and height were measured after the 
interview. Height was measured without shoes and corrected 
to the nearest millimetres. Weight was measured with light 
clothing on and without shoes. The percentage body fat was 
calculated from the measured skinfold thickness values. 
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Relative body fat 
The percentage body fat was calculated using the MOHR 
equation (Cole and Udekwe, 1989) 
%BF = - 20 + 17.305 x log x1 + 12.012l logx2 +6.293 x logx3 
x1 = Skinfold triceps (mm) 
x2 = Skinfold Subscapular (mm) 
x3 = Skinfold Iliac crest (mm) (Cole and Udekwe,1989) 
Statistical analysis 
All results were expressed as means plus standard error of 
mean (X ± SEM). Student t-test and multivariate analysis of 
variance (ANOVA) were used for statistical comparisons 
using SPSS package. The difference was regarded as 
significant at p < 0.05. 
RESULTS  
Figure 1 shows distribution of all subjects within the different 
socio-economic classes. There was a preponderance of 
patients suffering from the different types of CVD in the low-
income group. The relative distributions of low, middle and 
high-income subject was 37:44:4, 23:17:8, 7:5:2 and 32:12:3 
for HT, IHD, MI and HHD respectively. The relative proportion 
of the corresponding control group was 15:13:1.  
Table 1: Biophysical and biochemical parameters in all 
subjects (Mean ± SEM) 
	  
TC=Total cholesterol; HDLC=High density lipoprotein cholesterol; 
LDLC=Low density lipoprotein cholesterol; TG=Triglyceride; NS=Not 
significant; n=Number of subject; SE=Standard error. 
 
Table 1 show the biophysical and biochemical parameters in 
all subjects. There were significant changes in the mean 
plasma TC (p < 0.05), HDLC, HDLC:TC and LDLC: HDLC (p 
< 0.001) as well as plasma TG (p < 0.01) in all the patients 
when compared with the corresponding mean control values. 
There were also significant increases in the mean systolic 
and diastolic blood pressure (p < 0.001). The %BF was 
significantly increased (p < 0.05) when compared with the 
corresponding mean control value. 
Table 2: Biochemical parameters in male and female 
patients and controls (Mean ± SEM) 
	  
Level of significance: (*P < 0.01, **P < 0.001); TC=Total cholesterol 
CVD=Cardiovascular disease; HDLC=High density lipoprotein 
cholesterol; LDLC=Low density lipoprotein cholesterol; 
TG=Triglyceride; NS=Not significant; n=Number of subject;  
SE=Standard error. 
 
Table 2 shows the biophysical and biochemical parameters 
in male and female patients and controls. The mean SBP of 
the patients was higher than the corresponding sex-matched 
mean control value (p < 0.001). The BMI and: %BF showed 
no significant changes. The female patients exhibited an 
elevated mean plasma TC and LDLC (p < 0.01) 
concentrations when compared with the male patients, the 
male patients had a significantly higher mean plasma TG (p < 
0.01) compared with the female controls. The male patients 
had lower mean plasma HDLC (p < 0.05) when compared 
with the controls. The mean plasma HDLC in the male 
patients was significantly lower than the level in the female 
controls. The mean HDLC:TC ratio was  reduced in both 
male and female patients (p < 0.001) when compared with 
the corresponding control values in male and female control 
subjects  respectively.  
Classification of patients into socioeconomic classes showed 
graded decreased in plasma HDLC. The low-income class 
had the lowest plasma HDLC. When these changes were 
subjected to within group analysis, no significant changes 
were obtained (Table 3). 
Table 4 shows the biochemical parameters in patients 
classified according to the disease types. Within group 
analysis of all parameters in the different subtypes of CVD 
showed significant variations in mean plasma HDLC and 
LDLC (p < 0.001) and HDLC:TC as well as LDLC: HDLC 
ratios (p < 0.001). The SBP and DBP (p < 0.001) were 
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significantly increased in all the disease types when 
compared with respective control values. Also the mean DBP 
reading was greater than the cut off pressure reading of ≥ 90 
mmHg only in HT and HHD patients, while the mean SBP 
reading was greater than the cut off pressure reading of ≥ 
140 mmHg in HT, IHD and HHD patients. The mean TC, 
%BF and BMI showed no significant changes in the different 
groups. 
Table 3: Socio-economic status, biophysical and 
biochemical parameters in CVD patients (Mean ± SEM) 
	  
TC=Total cholesterol CVD=Cardiovascular disease; HDLC=High 
density lipoprotein cholesterol; LDLC=Low density lipoprotein 
cholesterol; TG=Triglyceride; NS=Not significant; n=Number of 
subject; SE=Standard error. 
 
Table 5 shows the distribution of lipids and lipoproteins in all 
subjects. Patients with HT showed the highest increase in 
mean TC > 200 mg/dl, LDLC > 135 mg/dl and decrease in 
HDLC < 35 mg/dl in the different subtypes of CVD. 
DISCUSSION 
This study examined changes in lipids and lipoprotein within 
the different socio-economic classes in patients suffering 
from different types of CVD in Nigeria. The observations 
indicated that the subtypes of CVD exhibited variations in the 
mean plasma lipoprotein concentrations in the different 
socioeconomic groups. Of these variables, low plasma HDLC 
levels were more closely associated with socioeconomic 
status. Several large scale population studies have found an 
association between lipid variables and socioeconomic class 
in both men and women (Scottish Heart Health Study 
(Woodward et al., 1992) Minnesota Heart Survey, (Leupker 
et al., 1993).  Tromso Heart Study (Jacobsen and Telle 
1988), Framingham Offspring Study (Garrison et al., 1993) 
and Australian National Heart Foundation risk factor 
prevalence study (Simon et al., 1986). The tendency for low 
plasma HDLC was more evident in the low income group, 
while the highest level was obtained in the high income 
group. The association between low plasma HDLC and 
socioeconomic status found in the present study is in part in 
accordance with the findings from earlier studies elsewhere 
(Lipid Research Clinics program relevance study (Hesis et 
al., 1980), Framingham offspring study (Garrison et al., 1993) 
and Australian Study (Simon et al., 1986) where low plasma 
HDLC was obtained in unclassified normal subjects. High 
density lipoprotein cholesterol concentration in plasma is 
commonly seen as an indicator of the efficiency of the 
reverse cholesterol transport, and because of the inverse 
relationships between HDLC levels and coronary heart 
disease rate in different populations, plasma concentration is 
of immense value in atheroprotective mechanism. 
Stratification of patients into socio-economic groups showed 
that about 60% were in the low income class, while only 12% 
belonged to the high income class. 
        Table 4: Biochemical and biophysical parameters in the different types of CVD and controls  (Mean ± SEM) 
NS=Not significant; TC=Total cholesterol; HDLC= High density lipoprotein cholesterol; LDLC=Low density lipoprotein 
cholesterol; TG=Triglyceride; n=number of subjects. 
	  
Ebesunun et al. Plsama lipids and lipoprotein profiles of CVD patients in Nigeria  Biokemistri 25(2): 45–51 
 49	  
The large number of patients belonging to the low income 
class may be one important factor responsible for the rather 
small increase in mean plasma TC compared to the controls. 
A number of studies suggest that poor living conditions in 
childhood and adolescence contribute to increase risk of 
atherosclerosis (Hirdes and Forbes 1992, Leino et al., 2000).  
There are however limited studies of lipid profile in relations 
to subtypes of CVD and socioeconomic class. The highest 
increase in mean plasma LDLC concentration was found in 
HHD patients. The relative increases in the plasma LDLC 
was more pronounced than that in the plasma TC in all the 
patients, with the highest value obtained in IHD patients.   
The extent of changes in the mean lipid profile observed in 
this study may be a reflection of the heterogeneous nature of 
the patients studied.  
The mean plasma LDLC which is widely regarded as one of 
the most reliable risk factor for predicting the development of 
premature CVD in humans was slightly above acceptable 
reference value (> 135 mg/dl), with MI and HHD showing the 
highest mean values. Factors that may be important 
determinants of circulating cholesterol concentration include 
socioeconomic class (Taylor and   Agbedana, 1983), body 
composition (Segal et al., 1987) and gender (Taylor and   
Agbedana, 1983). 
This study also showed inter-group variations with graded 
increases in the mean plasma TC and decreases in HDLC 
within the three socioeconomic classes with the lowest value 
observed in the low income group while the highest value 
was seen in the high income group. Certain dietary factors 
known to influence the plasma level of TC may have 
accounted for this difference. The status may be related to 
higher total calorie, total fat and cholesterol intake as well as 
lack of physical activity. There were generalized decreases in 
the mean plasma HDLC within the different CVD groups with 
IHD patients showing the lowest value. These changes could 
be attributed to the severity of the disease. It is reported that 
more affluent Nigerians have higher plasma HDLC than the 
ones in the low income group (Taylor and Agbedana, 1983). 
Similarly, the female group was found to have higher mean 
plasma HDLC and HDLC:TC ratio levels than their male 
counterparts. This could be as a result of the age group 
studied, thus supporting in part an already established notion 
that women of childbearing age are less prone to coronary 
heart disease since estrogen is known to enhance favourable 
level of plasma HDLC. 
The relative proportion of the different lipoproteins as 
measured by LDLC:HDLC ratio has been reported to be 
more useful predictor of coronary artery disease in different 
populations (Segal et al., 1987; Taylor and Bamgboye, 1979).  
Furthermore, Siegrist et al. (1988) and Otho-Gomer et al. 
(1994) showed that adverse long lasting chronic job stress 
may increase the ratio of LDLC:HDLC. Stress was however 
not considered in this study. Although epidemiological studies 
demonstrated a significant relationship between risks of 
developing coronary heart disease and reduced plasma 
HDLC, the exact mechanisms by which plasma HDLC exerts 
this atheroprotective effect is still unresolved, but the reverse-
cholesterol transport mechanisms have been commonly 
proposed. It could also be speculated that the same dietary 
factors that influence the level of plasma total cholesterol 
may also have a similar effect on the plasma HDLC level. An 
earlier report by Goldbourt et al. (1997) has shown that 
plasma HDLC < 35 mg/dl increased mortality for coronary 
heart disease in men, independent of the TC level.  
The percentage of decreases in plasma HDLC in the 
subtypes of CVD from the control group showed IHD (30%), 
                                     Table 5: Percentage distribution of lipids and lipoproteins in all subjects 
 
TC=Total cholesterol; HDLC=High density lipoprotein cholesterol; LDLC=Low density lipoprotein cholesterol; TG=Triglyceride; 
HT=hypertension; HHD= hypertensive heart diseases; MI=myocardial infraction; IHD= ischemic heart disease; n=number of subjects, actual 
number of patients are shown in parentheses. 
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MI (21%), HHD (18.5%) and HT (18%) respectively, is 
suggesting that decreased HDLC is common with all the 
subtypes of CVD in this study. The desirability of raising 
HDLC is based on multiple lines of evidence; perhaps the 
most direct argument is that there is increase of about 2.5% 
in CVD risk for each mg/dl decrease in HDLC level 
(Goldbourt et al., 1997).  In the present study 34% of the 
cases studied were patients with hypertension, while only 
10% were MI patients. Physical activity and exercise are 
known to enhance plasma HDLC. Indications from the 
questionnaire revealed that many of these patients did not 
engage in any regulated physical exercise as a routine.  
The HDLC:TC ratio was reported as a useful and simple 
index of IHD risk in men in the Quebec Cardiovascular Study 
(Lemieux et al., 2001). It is proposed that the ability of this 
ratio to predict risk could be explained by the fact it is a 
relevant cumulative marker of the cluster of metabolic 
abnormalities found in individuals with high TG-low HDLC 
dyslipidemia. The mean plasma TG, a known independent 
risk factor for premature CVD, was significantly increased in 
the patients compared with value in the control group. It is 
important to note that slight intergroup variations occurred in 
the mean TG concentration within the disease subtypes. The 
highest increase in mean plasma TG was found in HT group, 
thus indicating a significant alteration of atherogenic lipid in 
this group, probably suggesting that the significant 
hypertriglyceridemia in all classes could be related to the 
constant finding of hypertension in all groups. It is noteworthy 
that in CVD of varying aetiology hypertriglyceridemia is a 
constant feature suggesting that dyslipidaemia could arise as 
a complication or part of the disease process (Garber and 
Avins, 1994) 
Conclusions 
HDL functions at an extravascular level, it is expected that 
decreases in levels of circulating HDLC as obtained in this 
study irrespective of mechanism, will not be able to confer 
protection against accelerated plaque formation in the 
patients. The present results indicate that decreased plasma 
mean HDLC is associated with the different types of CVD 
and varied within the socioeconomic classes. 
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